In Korea, drug audits include Good Manufacturing Practice (GMP) inspections, Good Clinical Practice (GCP) audits, and Good Laboratory Practice (GLP) assessments. These audits ensure compliance with regulatory standards, quality control, and safety protocols in pharmaceutical manufacturing, clinical trials, and laboratory testing, respectively.
